Buy Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension for Wholesale Order
What is Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension?
Cefpodoxime 50 mg combined with Clavulanic Acid 31.25 mg is a pharmaceutical oral suspension classified as a broad-spectrum cephalosporin antibiotic with beta-lactamase inhibitor. This combination effectively combats various bacterial infections by preventing bacterial cell wall synthesis.
Commonly utilized in the treatment of respiratory tract infections, ear infections, and skin infections, this suspension highlights its importance in both clinical and pharmaceutical synthesis contexts. Regulatory compliance is critical, with this compound being relevant in therapeutic applications requiring stringent quality standards.
What Are the Applications of Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension?
- Treatment of bacterial infections in pediatric and adult populations.
- Research purposes in microbiological studies.
- Used in formulation development for various medical applications.
- Potential application in veterinary medicine for animal infections.
Why Choose Pharmint as Your Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension Supplier?
Pharmint offers global sourcing capabilities for Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg Oral Suspension, ensuring compliance with regulatory standards. Our products come with a Certificate of Analysis (COA), Material Safety Data Sheet (MSDS), and are available in bulk quantities.
We provide competitive advantages over typical vendors, including reduced lead times and comprehensive export support tailored to your supply chain needs.
Storage & Handling Guidelines for Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension
Store this oral suspension at controlled room temperature (20°C to 25°C) in a tightly sealed container to protect from light and moisture. Ensure minimal air exposure to maintain stability. Available in bulk packaging suitable for both R&D and large-scale manufacturing.
Regulatory, Documentation & Export Information
This compound does not require an end-use declaration and is not categorized as a controlled precursor. Key documents available include COA and MSDS to ensure compliance with international regulations.
Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension FAQs
Where to buy Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension for bulk?
You can procure Cefpodoxime 50 mg + Clavulanic Acid 31.25 mg Oral Suspension in bulk directly from Pharmint. Contact our sales team for more information.
What is the shelf life of Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension?
The shelf life is typically 24 months when stored under recommended conditions. Always refer to the product COA for specific expiration dates.
Is Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension safe for children?
This formulation is designed for pediatric use; however, dosage should always be determined by a qualified healthcare professional.
What should I do if the oral suspension is discolored?
Do not use the product if it appears discolored or contains particles. Dispose of it properly and consult with your supplier.
Can Cefpodoxime 50 mg+Clavulanic Acid 31.25 mg Oral Suspension be used in research?
Yes, this suspension is suitable for research applications related to bacterial infections and antibiotic efficacy studies.
Revisiones
There are no reviews yet.